Treatment of huge HCC: Extending the indications for liver resection

Annals of Surgical Oncology

Volumn 15, Issue 5, 2008, Pages 1549-

  Kobayashi, Akihiko ^a   Pulitanò, Carlo ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CHEMOEMBOLIZATION; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER RESECTION; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS;

EID: 41549083008     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9773-1     Document Type: Letter

References (6)

1. Pandey D, Lee KH, Wai CT, et al. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 2007;14:2817-23.
2. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005;12:364-73.
3. Kobayashi A, Takahashi S, Ishii H, et al. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization. Eur J Surg Oncol 2007;33:1019-24.
4. Inoue K, Nakamura T, Kinoshita T, et al. Volume reduction surgery for advanced hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:362-6.
5. Hong K, Georgiades CS, Geschwind JF. Technology insight: Image-guided therapies for hepatocellular carcinoma-intra-arterial and ablative techniques. Nat Clin Pract Oncol 2006;3:315-24.
6. Lee SG, Hwang S, Jung JP, et al. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg 2007;94:320-6.